# A Study of Distal Jejunal-release Dextrose in Obese Participants

> **NCT05385978** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Aphaia Pharma US LLC** · enrollment: 150 (estimated)

## Conditions studied

- Obese

## Interventions

- **DRUG:** APHD-012
- **DRUG:** APHD-012P

## Key facts

- **NCT ID:** NCT05385978
- **Lead sponsor:** Aphaia Pharma US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-01
- **Primary completion:** 2024-11-11
- **Final completion:** 2024-11-11
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385978, "A Study of Distal Jejunal-release Dextrose in Obese Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05385978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*